Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ORGANIZATION
ORGANIZATION
- NPhA Refers Plan to Recommend Next President to Board Review
February 27, 2012
- Toshiki Iwasaki to Step Down as NPhA President in May
February 24, 2012
- JSCTR to Set Up“GCP Expert” Certification to Improve Quality of Clinical Studies
February 21, 2012
- Japan Pharmaceutical Political Association Chairman Kumakura to Focus on Resolving Price Difference
February 21, 2012
- Prof. Kimura of Saga Univ. Receives Top Award for Research on Ubiquilin 1 Inhibitor
February 17, 2012
- 12 Organizations from 11 Countries, Regions to Participate in Asian Cooperation Conference
February 16, 2012
- JPMA VP Nogimori Focused on Thorough Compliance, Promotion of International Cooperation
February 15, 2012
- KIF5B-RET Fusion Gene Identified as Potential Target in Pulmonary Adenocarcinoma
February 13, 2012
- NPhA Compiles Draft Proposal for Mutual Understanding to Improve Distribution
February 10, 2012
- MHLW “Missing the Bigger Picture” in Measures to Eliminate Drug Lag: Prof. Nakamura
February 10, 2012
- PhRMA Concerned that Health Economic Evaluation Will Be Used to Reduce NHI Prices: Mr Zulueta
February 6, 2012
- JACDS to Strengthen Support to Ensure Compliance in Sale of OTC Drugs
February 6, 2012
- It Is Difficult to Check Off-Label Use of Generics Approved for Indications Different from Those of Original Drugs: Medical Bill Payment Fund
February 1, 2012
- JPMA to Make Proposals on Pricing of Long-Listed Drugs to CSIMC: President Teshirogi
January 31, 2012
- BG Kansai to Establish Service Hub to Support Use of Supercomputers in Drug Discovery
January 31, 2012
- MHLW, JPWA Hold Public-Private Dialogue on Distribution Improvement
January 30, 2012
- JPWA Board of Directors Approve By-Category Talks to Be Common Understanding
January 27, 2012
- JPA Supports Ban on “Dispensing Point” Services at Pharmacies
January 26, 2012
- JSMI to Seek Expansions of OTCs by Appealing Preventive Effects in 2012
January 24, 2012
- JPMA to Focus on Thorough Enforcement of Compliance in Next Fiscal Year
January 20, 2012
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…